J Neurol Neurosurg Psychiatry 76:1115-1120 doi:10.1136/jnnp.2003.035428
  • Paper

Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin

  1. M Odaka,
  2. M Tatsumoto,
  3. K Susuki,
  4. K Hirata,
  5. N Yuki
  1. Department of Neurology, Dokkyo University School of Medicine, Shimotsuga, Tochigi, Japan
  1. Correspondence to:
 M Odaka
 Department of Neurology, Dokkyo University School of Medicine, Kitakobayashi 880, Mibu, Shimotsuga, Tochigi 321-0293, Japan;
  • Received 29 December 2003
  • Accepted 18 November 2004
  • Revised 16 November 2004


Background: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous disorder and both clinical course and response to treatment vary widely. Because of the propensity for relapse, CIDP requires maintenance therapy after the initial response to treatment. There is no consensus regarding this in the published literature.

Present report: A patient with CIDP was treated with oral prednisolone and cyclophosphamide pulse therapy but required repeated plasma exchange and intravenous immunoglobulin (IVIg). Treatment with ciclosporin freed the patient from repeated IVIg administration. Therapeutic responses in 14 subsequent cases including three patients who showed improvement with ciclosporin are also presented along with an algorithm of the authors’ suggested protocol for treatment.

Conclusion: Ciclosporin should be considered for patients with intractable CIDP who require repeated IVIg.


  • Competing interests: none declared

  • Patient consent was obtained.

Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article